These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 38549161)

  • 1. Immune cells: potential carriers or agents for drug delivery to the central nervous system.
    Zhang SS; Li RQ; Chen Z; Wang XY; Dumont AS; Fan X
    Mil Med Res; 2024 Mar; 11(1):19. PubMed ID: 38549161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the Brain Barriers: From Immune Cells to Nanoparticles.
    Charabati M; Rabanel JM; Ramassamy C; Prat A
    Trends Pharmacol Sci; 2020 Jan; 41(1):42-54. PubMed ID: 31839374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
    Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
    Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L; Rosch J; Putnam D
    J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS therapeutics: Immune cells break the barriers.
    Thai K; Prat A
    Sci Transl Med; 2023 Nov; 15(721):eadh1150. PubMed ID: 37939159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles-based delivery system and its potentials in treating central nervous system disorders.
    Liu T; Xie Q; Dong Z; Peng Q
    Nanotechnology; 2022 Aug; 33(45):. PubMed ID: 35917704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles for drug delivery to the central nervous system.
    Patel T; Zhou J; Piepmeier JM; Saltzman WM
    Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier.
    Tan Q; Zhao S; Xu T; Wang Q; Lan M; Yan L; Chen X
    J Mater Chem B; 2022 Nov; 10(45):9314-9333. PubMed ID: 36349976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
    Sa P; Singh P; Dilnawaz F; Sahoo SK
    Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic iron oxide nanoparticles for brain imaging and drug delivery.
    Qiao R; Fu C; Forgham H; Javed I; Huang X; Zhu J; Whittaker AK; Davis TP
    Adv Drug Deliv Rev; 2023 Jun; 197():114822. PubMed ID: 37086918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS.
    Gondim BLC; da Silva Catarino J; de Sousa MAD; de Oliveira Silva M; Lemes MR; de Carvalho-Costa TM; de Lima Nascimento TR; Machado JR; Rodrigues V; Oliveira CJF; Cançado Castellano LR; da Silva MV
    Curr Pharm Des; 2019; 25(37):3983-3996. PubMed ID: 31612822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges.
    Wu H; Zhang T; Li N; Gao J
    J Control Release; 2023 Aug; 360():169-184. PubMed ID: 37343724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges.
    Karami Z; Saghatchi Zanjani MR; Hamidi M
    Drug Discov Today; 2019 May; 24(5):1104-1115. PubMed ID: 30914298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
    Ceña V; Játiva P
    Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of Nanomedicine to the CNS Diseases.
    Carradori D; Gaudin A; Brambilla D; Andrieux K
    Int Rev Neurobiol; 2016; 130():73-113. PubMed ID: 27678175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease.
    Hernando S; Santos-Vizcaíno E; Igartua M; Hernandez RM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1898. PubMed ID: 37157144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.